Many Drug Manufacturing Sites Pay A Stiff Price For Ignoring US FDA Remote Records Requests
Executive Summary
The FDA has been import-alerting more and more facilities for failing to respond to its remote records requests, FDA compliance official says. Meanwhile, it appears the agency’s generous exercise of regulatory discretion during the pandemic in cases of serious noncompliance is coming to an end.